搜索临床试验以:实验:EVP-6124
总计3712个结果
-
Otsuka Pharmaceutical Development & Commercialization...完全的
-
Mespere Lifesciences Inc.Wayne State University未知
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
National Center for Research Resources (NCRR)HRSA/Maternal and Child Health Bureau完全的
-
Merit Medical Systems, Inc.University of Colorado, Denver; Mayo Clinic; University of Florida; Medical College of Wisconsin; Weill... 和其他合作者完全的
-
University of Alabama, TuscaloosaUAB Resource Centers for Minority Aging Research (RCMAR)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 晚期恶性实体瘤 | 不可切除的恶性实体肿瘤 | 转移性恶性实体瘤 | 复发性乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | TP53 wt 等位基因美国
-
Northwestern UniversityBreast Cancer Research Foundation; Repros Therapeutics Inc.未知